Program Description: 

In today’s changing healthcare environment, patient care delivery models must evolve to ensure the focus is on efficient, effective utilization of laboratory services to improve patient care while reducing healthcare costs and unnecessary testing. Exponential growth of genomic testing and patient demand for dialogue with clinicians will require that the pathologist play a leadership role in promoting and managing the delivery and use of healthcare resources, and initiating these conversations about appropriate test use with clinicians and patients. As leaders of the multidisciplinary care team, pathologists have an ethical responsibility to reduce healthcare costs vis-a-vis proven clinical outcomes. Treatment must be considered based on data driven evidence rather than the latest molecular fad. Personalized medicine is well suited to support reforms that promote paying for value or outcomes rather than paying for volume or procedure. Healthcare institutions seeking to reduce unnecessary testing should encourage open lines of communication between pathologists and laboratory professionals—who perform and interpret the tests—and the clinicians who prescribe them. Collaborative efforts are essential for improving quality of care and health outcomes while reducing errors and expenses. This will require communication, education, outcome measurement and management and appropriate use of health information technology.

ACCME Accreditation Statement:

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

AMA Credit Designation:

The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Hours of Participation for Allied Health Professionals:

The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 
Physicians
Physician's Assistants
 
Learning objectives: 

At the conclusion of this activity, learners will be able to:

  • Describe the concept of "appropriate test utilization" and the role fo the pathology laboratory team in its determination
  • Relate at least two roles of the "pathologist as consultant" as a participant in genomic medicine
  • Explain at least three "evolutionary implications for pathology" on the immediate horizon
  • Review updates to "Choosing Wisely"
  • Highlight a new opportunity for pathologist engagement in advancing global health
Faculty & credentials: 
Planning Committee:
Saul Suster, MD
 
Presenter(s):
E. Blair Holladay, Ph.D., SCT(ASCP)CM
Chief Executive Officer
American Society for Clinical Pathology

All persons in control of content have NO relevant financial relationships to disclose except the following:

N/A

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following and in accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Contact

Name: 
Shannon Majewski
Phone number: 
+1 (414) 805-6976

 

Session date: 
03/27/2018 - 12:15pm to 1:15pm CDT
Location: 
Pathology Conference Room 247
9200 W Wisconsin Avenue, WDL Building, Second Floor
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.